You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Liz Wager: Research integrity—how can institutions balance discipline and support?

11 Aug, 14 | by BMJ

lizwagerThe suicide of Yoshiki Sasai is both tragic and shocking. Sasai was deputy director of the RIKEN Center for Developmental Biology, and a co-author of reports in Nature on the phenomenon of “stimulus-triggered acquisition of pluripotency” (or STAP), which were retracted. Although Sasai was not accused of misconduct himself, he was criticised in an institutional investigation for failing to check the data produced by his more junior colleague, Haruko Obokata.

I have been following this case closely, as just two weeks ago I gave a seminar on publication ethics at the RIKEN Institute in Tokyo. I also ran a workshop at Waseda University, where I arrived to discover that a committee was considering Obokata’s PhD dissertation that very afternoon.

Several people asked me what I thought about the case, but as the investigations were still under way, and the team attempting to replicate the findings had not yet reported, I declined to comment on whether this was fraud or honest error. However, I did praise the institution’s prompt and apparently thorough investigations. I also said that I thought it was a good thing the case was getting so much media attention, but now I am not so sure.

I remain convinced that secrecy is unhelpful, and that institutions should be open about cases of suspected and proved misconduct. Too many cases have been ignored or covered up, with fraudsters encouraged to leave quietly and seek another job, while whistleblowers are silenced.

I also believe that public debate is important, and that society needs to understand the pressures placed on researchers and the problems that occasionally arise. Serious misconduct is—fortunately—rare, but denying its existence is both naïve and unhelpful.

But the tragic death of Dr Sasai reminds us that transparency and scrutiny must be accompanied by support for the individuals affected. A few months ago, I spoke to the dean of a major West European institution about its policy of not releasing the names of individuals found guilty of misconduct to the media, even though affected journals were informed, and therefore this information was available in retraction notices.

He emphasised the dual responsibility of the institution not only to investigate (and rectify) misconduct, but also to protect its employees. In the case we were discussing, there had been extensive media coverage and the researcher was considered at risk of suicide (showing that this cannot be considered a peculiarly Japanese problem). I was impressed by this approach combining both discipline and care.

I will continue to call for greater transparency around research integrity, and, until that is the norm, will welcome informed debate. But this sad story from Japan should remind us of the harmful effects that such debate may have, which we should try to minimise. As with so many aspects of misconduct and integrity, it’s a difficult balance, but one that research institutions should strive to achieve.

Liz Wager PhD is a freelance medical writer, editor, and trainer. She was the chair of the Committee on Publication Ethics (COPE) (2009-2012).

Competing interests: The author has no further relevant interests to declare.

By submitting your comment you agree to adhere to these terms and conditions
  • Miguel Roig

    The dean of a Western European university “emphasised the dual responsibility of the institution not only to investigate (and rectify) misconduct, but also to protect its employees”. That may be, but my sense is that more often than not the actions of some institutions engaged in misconduct investigations seem more like efforts to protect the institution than to rectify misconduct or protect its employees.

  • elegiamore

    Suicide is a choice. But falsifying medical data, which can cause OTHERS to die, is not the individual’s choice. Therefore protecting the fraudster so as to protect their ego, even the slightest, is a miscarriage of justice and physician’s oaths. I am at a loss as to why any researcher needs emotional protection, as I am assuming they are adults in a position of importance. The author is showing much to much concern for the researcher when again, it is the public that pays.

  • elegiamore

    Then it’s about time we started lowering the boom any institution that can be shown to have falsified research data. Isn’t it malpractice at best and murder otherwise?

You can follow any responses to this entry through the RSS 2.0 feed.
BMJ blogs homepage

The BMJ

Helping doctors make better decisions. Visit site



Creative Comms logo

Latest from The BMJ

Latest from The BMJ

Latest from BMJ podcasts

Latest from BMJ podcasts

Blogs linking here

Blogs linking here